Global DNA Sequencing Market 2022
- 市场报告
- ID: HB24309G
- 交货时间: 1 工作日
- 标签: DNA Sequencing
描述
DNA sequencing is a laboratory technique used to determine the exact sequence of bases (A, C, G, and T) in a DNA molecule. The DNA base sequence carries the information a cell needs to assemble protein and RNA molecules. DNA sequence information is important to scientists investigating the functions of genes. A study by StrategyHelix indicates that the global DNA sequencing market is expected to increase by US$ 28.7 十亿来自 2022 到 2028, 复合年增长率为 18.1% 在预测期内.
该报告提供了该时期的最新市场规模数据 2018-2021 并预测到 2028 covering key market aspects like sales value for DNA sequencing. The global DNA sequencing market is segmented on the basis of product, sequencing type, 应用, 和地区. 根据产品, the global DNA sequencing market is categorized into sequencing services, sequencing instruments, sequencing consumables, sequencing informatics. Sequencing services held the highest share in the global dna sequencing market. 然而, the sequencing informatics segment is forecast to register the highest CAGR during the forecast period 2022 – 2028. On the basis of sequencing type, the global DNA sequencing market has been segmented into next generation sequencing (NGS), sanger sequencing, 其他的. The NGS segment captured the largest share of the market in 2021. 按申请, the global DNA sequencing market has been segmented into applied, clinical, 研究. 从地理上来说, the global DNA sequencing market has been segmented into Asia Pacific, 欧洲, 北美, 世界其他地区 (排). North America held the largest revenue share in 2021.
The global DNA sequencing market is highly competitive. 作为 2021, the major players in the global DNA sequencing market were Adaptive Biotechnologies Corp., Agilent Technologies Inc., Ambry Genetics Corporation, BD (Becton Dickinson and Company), Berry Genomics Co. 有限公司, BGI Group, Biodesix Inc., CareDx Inc., Centogene AG, Danaher Corporation, Devyser Diagnostics AB, Illumina Inc., Macrogen Inc., Merck KGaA, myDNA Inc., Natera Inc., NeoGenomics Laboratories Inc., New England Biolabs Inc., NGeneBio Co. 有限公司, Oxford Nanopore Technologies Limited, Pacific Biosciences of California Inc., PerkinElmer Inc., Personalis Inc., Qiagen N.V., Quest Diagnostics Inc., Roche Holding AG, SOPHiA GENETICS, TAKARA BIO INC., Thermo Fisher Scientific Inc.
该报告对于活跃在该行业的公司和组织来说是宝贵的资源. It provides a cohesive picture of the DNA sequencing market to help drive informed decision making for industry executives, 政策制定者, 学术的, 和分析师.
报告范围
产品: sequencing services, sequencing instruments, sequencing consumables, sequencing informatics
Sequencing type: next generation sequencing (NGS), sanger sequencing, 其他的
应用: applied, clinical, 研究
地区: 亚太地区, 欧洲, 北美, 世界其他地区 (排)
考虑的年数: 本报告涵盖期间 2018 到 2028
利益相关者的主要好处
– Get a comprehensive picture of the global DNA sequencing market
– 精准定位增长领域和投资趋势
目录
部分 1. 介绍
– 研究范围
– 学习时段
– 地理范围
– 研究方法论
部分 2. DNA sequencing market overview
部分 3. 按产品划分的市场细分
– Sequencing services
– Sequencing instruments
– Sequencing consumables
– Sequencing informatics
部分 4. Market breakdown by sequencing type
– Next generation sequencing (NGS)
– Sanger sequencing
– 其他的
部分 5. 按应用划分的市场细分
– Applied
– Clinical
– Research
部分 6. 按地区划分的市场细分
– 亚太地区
– 欧洲
– 北美
– 世界其他地区 (排)
部分 7. 重点企业
– Adaptive Biotechnologies Corp.
– Agilent Technologies, 公司.
– Ambry Genetics Corporation
– BD (Becton, Dickinson and Company)
– Berry Genomics Co., 有限公司.
– BGI Group
– Biodesix, 公司.
– CareDx, 公司.
– Centogene AG
– Danaher Corporation
– Devyser Diagnostics AB
– Illumina, 公司.
– Macrogen, 公司.
– Merck KGaA
– myDNA Inc.
– Natera, 公司.
– NeoGenomics Laboratories, 公司.
– New England Biolabs, 公司.
– NGeneBio Co., 有限公司.
– Oxford Nanopore Technologies Limited
– Pacific Biosciences of California, 公司.
– PerkinElmer, 公司.
– Personalis, 公司.
– Qiagen N.V.
– Quest Diagnostics Inc.
– Roche Holding AG
– SOPHiA GENETICS
– TAKARA BIO INC.
– Thermo Fisher Scientific Inc.
关于StrategyHelix
免责声明